CVE:SCYB

Scythian Biosciences Stock Forecast, Price & News

C$3.49

-0.22 (-5.93 %)

(As of 07/25/2018)

Add

Compare

Today's Range

C$3.46

Now: C$3.49▼

C$3.77

50-Day Range

C$3.49

MA: C$3.49▼

C$3.49

52-Week Range

C$1.01

Now: C$3.49▼

C$8.61

Volume703,164 shs

Average Volume231,491 shs

Market CapitalizationC$102.38 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

Overall MarketRank^™

0.52 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Scythian Biosciences.

2.6 Community Rank

Outperform Votes
Scythian Biosciences has received 36 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Scythian Biosciences has received 32 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Scythian Biosciences has received 52.94% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Scythian Biosciences and other stocks. Vote “Outperform” if you believe SCYB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SCYB will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Scythian Biosciences does not currently pay a dividend.
Dividend Growth
Scythian Biosciences does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Scythian Biosciences insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange CVE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolCVE:SCYB

Previous Symbol

CUSIPN/A

CIKN/A

Webscythianbio.com

Phone+1-416-3669192

EmployeesN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares29,334,000

Market CapC$102.38 million

Next Earnings DateN/A

OptionableNot Optionable

C$3.49

-0.22 (-5.93 %)

(As of 07/25/2018)

30 days | 90 days | 365 days | Advanced Chart

Receive SCYB News and Ratings via Email

Sign-up to receive the latest news and ratings for SCYB and its competitors with MarketBeat's FREE daily newsletter.

Scythian Biosciences (CVE:SCYB) Frequently Asked Questions

What stocks does MarketBeat like better than Scythian Biosciences?

Wall Street analysts have given Scythian Biosciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Scythian Biosciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Scythian Biosciences' key competitors?

Some companies that are related to Scythian Biosciences include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena plc (ABZA.L) (ABZA), Acrux Limited (ACR.AX) (ACR), Actinogen Medical Limited (ACW.AX) (ACW), AdAlta Limited (1AD.AX) (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Alaric (HALB) and Algernon Pharmaceuticals (AGNPF).
View all of SCYB's competitors.

What other stocks do shareholders of Scythian Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scythian Biosciences investors own include Brookfield Property Partners (BPY), Cross Timbers Royalty Trust (CRT), Archer-Daniels-Midland (ADM), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), OrganiGram Holdings Inc. (OGI.TO) (OGI), Roku (ROKU), Scythian Biosciences (SCCYF) and Abbott Laboratories (ABT).

Who are Scythian Biosciences' key executives?

Scythian Biosciences' management team includes the following people:

Mr. Rob Reid, CEO & Director
Mr. Jonathan James Held, Chief Financial Officer (Age 32)
Mr. Maghsoud Dariani, Chief Scientific Officer (Age 65)
Prof. Michael Barnes, Chief Medical Officer

What is Scythian Biosciences' stock symbol?

Scythian Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SCYB."

How do I buy shares of Scythian Biosciences?

Shares of SCYB and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Scythian Biosciences' stock price today?

One share of SCYB stock can currently be purchased for approximately C$3.49.

How big of a company is Scythian Biosciences?

Scythian Biosciences has a market capitalization of C$102.38 million.

What is Scythian Biosciences' official website?

The official website for Scythian Biosciences is scythianbio.com.

How can I contact Scythian Biosciences?

Scythian Biosciences' mailing address is 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada. The company can be reached via phone at +1-416-3669192.

This page was last updated on 1/20/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Scythian Biosciences Stock Forecast, Price & News

Adding